Fate Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FATE and other ETFs, options, and stocks.

About FATE

Fate Therapeutics, Inc. engages in the development of programmed cellular immunotherapies for cancer and immune disorder. Its pipeline of products includes immuno-ocology candidates and immuno-regulation candidates.

CEO

Bahram Valamehr

CEOBahram Valamehr

Employees

181

Employees181

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

2007

Founded2007

Employees

181

Employees181

FATE Key Statistics

Market cap

175.88M

Market cap175.88M

Price-Earnings ratio

-1.01

Price-Earnings ratio-1.01

Dividend yield

—

Dividend yield—

Average volume

3.21M

Average volume3.21M

High today

$1.56

High today$1.56

Low today

$1.47

Low today$1.47

Open price

$1.50

Open price$1.50

Volume

1.06M

Volume1.06M

52 Week high

$3.50

52 Week high$3.50

52 Week low

$0.6611

52 Week low$0.6611

Analyst ratings

55%

of 11 ratings

Buy

45.5%

Hold

54.5%

Sell

People also own

Based on the portfolios of people who own FATE. This list is generated using Robinhood data, and it’s not a recommendation.